Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-7-23
|
pubmed:abstractText |
A prospective neurological and electroencephalographic (EEG) study was performed in sixteen leukemia patients receiving busulfan (BU) and cyclophosphamide before autologous bone marrow transplantation. All patients were given anticonvulsant prophylaxis with a combination of phenobarbital (PB) and clonazepam (CLZ). Neurological examination and EEG were performed prior to and soon after completion of BU treatment and were repeated two months later. No tonic-clonic and/or myoclonic convulsions were observed. In two patients, comparison of EEG recorded before and upon completion of BU administration revealed modification of features. EEG re-evaluated two months after BU showed normalization in one of the two patients. BU may trigger both generalized and myoclonic seizures together with EEG abnormalities; PB combined with CLZ may be useful prophylactic treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0390-6078
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
532-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8647520-Adolescent,
pubmed-meshheading:8647520-Adult,
pubmed-meshheading:8647520-Anticonvulsants,
pubmed-meshheading:8647520-Bone Marrow Transplantation,
pubmed-meshheading:8647520-Busulfan,
pubmed-meshheading:8647520-Clonazepam,
pubmed-meshheading:8647520-Epilepsies, Myoclonic,
pubmed-meshheading:8647520-Female,
pubmed-meshheading:8647520-Humans,
pubmed-meshheading:8647520-Leukemia, Myeloid,
pubmed-meshheading:8647520-Male,
pubmed-meshheading:8647520-Middle Aged,
pubmed-meshheading:8647520-Transplantation, Autologous
|
pubmed:articleTitle |
Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients.
|
pubmed:affiliation |
Department of Biopathology, University La Sapienza, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|